Reporting person on SEC Form 4

Matthew Gregory Cohen

Matthew Gregory Cohen is Director at Arrowhead Pharmaceuticals. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jun 18, 2026, each linked to the official Form 4.

Director

Disclosures on record

1

Companies involved

1

Disclosure history

Arrowhead PharmaceuticalsARWR
Jun 15, 202612Kdisclosed Jun 18
Details Official record